| ATPC 0.1158 65.43% | MTEN 0.0332 -5.95% | OCG 0.0099 -16.10% | SOXS 2.0697 -9.22% | AUID 1.9199 93.44% | CJMB 4.03 259.82% | IVP 0.0514 -37.32% | ZSL 2.8799 2.31% | NVDA 189.4801 3.46% | SLV 83.88 -0.80% | SPHL 16.86 649.33% | INTC 49.04 0.66% | ASST 0.9901 -3.87% | DVLT 0.745 3.73% | BNKK 4.175 50.18% | TZA 5.9265 -3.79% | APLT 0.1 0.10% | SOXL 60.8798 9.93% | TQQQ 55.4888 3.08% | BYND 1.0415 8.28% | GRAB 4.37 -5.62% | BBAI 6.4 2.24% | ONDS 13.575 0.11% | IBRX 3.9 29.14% | DUST 5.735 -1.04% | NVD 6.9084 -6.77% | TSLL 18.4101 1.88% | EEM 58.3301 1.00% | TSLS 5.135 -1.06% | BITO 13.315 -1.81% | DNN 3.551 1.75% | AAL 15.735 3.93% | PLUG 2.315 -1.49% | MSTX 4.93 -5.19% | SPY 694.945 0.66% | AMD 236.845 5.92% | JDST 2.075 -1.43% | NOK 6.715 5.58% | IBIT 54.45 -1.79% | RZLV 4.7555 17.13% | FNGD 5.375 -2.45% | SIDU 3.745 -0.13% | XLE 47.815 -0.51% | QQQ 625.95 1.03% | GPUS 0.2932 -8.63% | VALE 14.795 1.27% | TSM 344.39 5.28% | TSLA 443.57 0.99% | ACHR 9.215 3.42% | SQQQ 64.8865 -3.07%

HB Fuller Upgraded To Buy At Seaport Global, Shares Rise 1%

Seaport Global Securities upgraded HB Fuller (NYSE: FUL) from Neutral to Buy with a price target of $80.00, sending shares up more than 1% pre-market on Friday.

The firm said HB Fuller was positioned to deliver strong year-on-year EBITDA growth in fiscal 2025 despite sluggish demand, citing margin expansion supported by lower costs and mix improvements. Analysts noted that EBITDA margin rose 110 basis points year-over-year even as volumes declined, reflecting effective execution in pricing, procurement, portfolio restructuring, and manufacturing optimization.

Engineering Adhesives led growth with a 14% EBITDA increase, while Building Adhesive Solutions also outperformed underlying markets, aided by demand from data center construction and growth in the Middle East. The Hygiene, Health & Consumables segment was weaker but saw partial offset from medical applications.

Seaport projected additional $25 million in price/cost tailwinds in FY26 and roughly $70 million in optimization benefits through FY30. At 7.8x forward EBITDA, below the 3-year average of 9.0x, analysts said the valuation supported the upgrade.


 

Published on: September 26, 2025